Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Reeve

Showing results (361-370 of 393) with videos related to

Pageof 40
Sort By:
JCO Clinical Cancer Informatics|October 28, 2020
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT TrialEthan Basch, Angela M Stover, Deborah Schrag, et al.
JMIR Human Factors|July 18, 2018
Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability StudyMartin W Schoen, Ethan Basch, Lori L Hudson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsChantal Quinten, Corneel Coens, Irina Ghislain, et al.
Pediatric Blood & Cancer|September 22, 2016
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiativeBryce B Reeve, Molly McFatrich, Laura C Pinheiro, et al.
Journal of the National Cancer Institute|October 21, 2022
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trialsMichael E Roth, Susan K Parsons, Patricia A Ganz, et al.
JCO Oncology Practice|August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer MeasureYashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
The Lancet. Oncology|February 1, 2023
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working groupClaire Piccinin, Ethan Basch, Vishal Bhatnagar, et al.
Translational Behavioral Medicine|September 28, 2013
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Deborah Watkins Bruner, Laura J Hanisch, Bryce B Reeve, et al.
Breast Cancer Research and Treatment|November 5, 2021
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancerK A Nyrop, E M Damone, A M Deal, et al.
Cancer|November 20, 2020
Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Yi Tang Chen, et al.
Pageof 40

Showing results (361-370 of 393) with videos related to

Sort By:
Pageof 40
JCO Clinical Cancer Informatics|October 28, 2020
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT TrialEthan Basch, Angela M Stover, Deborah Schrag, et al.
JMIR Human Factors|July 18, 2018
Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability StudyMartin W Schoen, Ethan Basch, Lori L Hudson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsChantal Quinten, Corneel Coens, Irina Ghislain, et al.
Pediatric Blood & Cancer|September 22, 2016
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiativeBryce B Reeve, Molly McFatrich, Laura C Pinheiro, et al.
Journal of the National Cancer Institute|October 21, 2022
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trialsMichael E Roth, Susan K Parsons, Patricia A Ganz, et al.
JCO Oncology Practice|August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer MeasureYashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
The Lancet. Oncology|February 1, 2023
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working groupClaire Piccinin, Ethan Basch, Vishal Bhatnagar, et al.
Translational Behavioral Medicine|September 28, 2013
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Deborah Watkins Bruner, Laura J Hanisch, Bryce B Reeve, et al.
Breast Cancer Research and Treatment|November 5, 2021
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancerK A Nyrop, E M Damone, A M Deal, et al.
Cancer|November 20, 2020
Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Yi Tang Chen, et al.
Pageof 40